Future-Proofing Cell-Based Therapies with Recombinant Culture Advancements
As biologics dominate the pharmaceutical development pipeline, the recombinant cell culture supplement market is gaining prominence for its ability to meet the rigorous demands of production-scale operations. Today, biopharmaceutical manufacturing facilities are under immense pressure to produce higher yields, meet stricter regulatory standards, and reduce contamination risks. Traditional...
0 Comments 0 Shares 847 Views 0 Reviews